Cite
MLA Citation
L Derikx et al.. “P579 Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohns's disease.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i519–i520. http://access.bl.uk/ark:/81055/vdc_100150514895.0x00002d